Healthcare, Pharma & Life Sciences

Cytrellis Expands ellacor Skin-Tightening Device Into South Korea

Image
Cytrellis Expands ellacor Skin-Tightening Device Into South Korea

Woburn, Mass. – – September 30, 2026 -- Cytrellis Biosystems, Inc. has signed a commercialization agreement with KoreAx Co. Ltd. to launch its ellacor skin-removal device in South Korea, marking the company's second international market entry of 2026 after Australia.

South Korea's Ministry of Food and Drug Safety cleared ellacor in 2025

Ellacor is described as the first and only FDA-cleared, minimally invasive, in-office procedure that removes sagging skin without surgery or thermal energy. The device uses Micro-Coring technology and is approved for adults aged 22 and older with Fitzpatrick skin types I-IV.

Pathology Ventures Names Ex-Banker Stockey EVP for Sponsor Deals

Image
Pathology Ventures Names Ex-Banker Stockey EVP for Sponsor Deals

Shreveport, La. – September 30, 2026 -- Pathology Ventures, LLC (PVL), a physician-founded network representing more than 500 pathologists, has appointed Dominic Stockey as executive vice president to lead partnerships with pharmaceutical, diagnostic and research sponsors.

Former investment banker to run sponsor and enterprise development

Stockey joins PVL after seven years in investment banking, where he served as Vice President and worked on more than 15 closed transactions across diagnostics, life sciences and healthcare, including mergers and acquisitions and capital formation deals. At PVL, he will oversee business operations, sponsor and partner relationships, commercialization, contracting and program execution.

PhRMA Names Eric Cantor as Next President and CEO, Effective Nov. 9

Image
PhRMA Names Eric Cantor as Next President and CEO, Effective Nov. 9

Washington – September 29, 2026 -- The Pharmaceutical Research and Manufacturers of America (PhRMA) has named former House Majority Leader Eric Cantor as its next president and chief executive officer, effective November 9. Cantor succeeds Stephen J. Ubl, who has led the trade group since 2015 and will remain as a strategic advisor through January 15, 2027.

Dimora Medical Launches MegaSorb Foam Dressing for Elderly Wound Care

Image
Dimora Medical Launches MegaSorb Foam Dressing for Elderly Wound Care

New York – – September 29, 2026 -- Dimora Medical unveiled a silicone foam wound dressing built on its MegaSorbTM Dual-Action Absorption System, targeting moderate to heavy exudate wounds common among elderly patients with pressure ulcers and chronic wounds. The launch coincides with the 2026 United Nations International Day of Older Persons, observed under the theme "The Age of Longevity: Rethinking Systems for Longer Lives."

MegaSorb foam absorbs up to 15 times its own weight in wound exudate

The dressing uses a high-porosity polymer with an open-cell structure reaching up to 90%, enabling it to lock in exudate within one second and reduce leakage and backflow risk. Dimora Medical positions the technology as a direct response to gaps in traditional wound dressings, which frequently fail to manage moderate to heavy exudate, causing maceration of surrounding skin and painful dressing changes.

Viatris Named to Forbes World's Best Employers List for Sixth Year

Image
Viatris Named to Forbes World's Best Employers List for Sixth Year

Pittsburgh – September 29, 2026 -- Viatris Inc. (Nasdaq: VTRS) has been named to Forbes' World's Best Employers list for the sixth consecutive year, based on an independent survey of more than 300,000 employees across over 50 countries.

Forbes and Statista ranked 900 companies using employee trust and workplace culture data

The 2026 ranking, compiled by Forbes and Statista, drew on respondents who rated their willingness to recommend their employer on a 1-to-10 scale. Participants evaluated current and former employers across multiple workplace factors and could also weigh in on other companies within their country and industry.

Viatris cites the recognition as validation of its global workforce strategy

Lara Ramsburg, Chief People and Corporate Affairs Officer at Viatris, said the sixth straight placement reflects the contributions of colleagues worldwide who help the company support patients while fostering a collaborative culture.

Maryland Stem Cell Fund Awards $4.8M as Demand Outpaces Capital

Image
Maryland Stem Cell Fund Awards $4.8M as Demand Outpaces Capital

Columbia, Md. – September 29, 2026 -- The Maryland Stem Cell Research Commission has awarded more than $4.8 million through the Maryland Stem Cell Research Fund (MSCRF) in the first funding cycle of fiscal year 2027, backing 15 investigators across the state's regenerative medicine sector.

Applications for MSCRF funding continue to exceed available resources

Requested funding significantly outstripped the capital available for this cycle, according to the Commission, reflecting both the depth of Maryland's research base and a rising number of technologies advancing past early discovery into validation, clinical development and manufacturing—stages that require substantially more capital.

Solis Mammography Enters South Carolina Via HCA Trident JV

Image
Solis Mammography Enters South Carolina Via HCA Trident JV

Charleston, SC – – September 29, 2026 -- Solis Mammography has formed a joint venture with HCA Healthcare Trident Hospital, marking the company's first entry into South Carolina and its 26th major market nationwide.

Trident Hospital's breast imaging unit rebrands under the Solis name

The partnership converts Trident Hospital's existing breast imaging services into Solis Mammography, a department of HCA Healthcare Trident Hospital, located at 9313 Medical Plaza Dr., Suite 201, Charleston. The companies plan to expand the model into additional HCA Healthcare facilities across the greater Charleston area.

eMed, Female Quotient Partner to Close $1 Trillion Women's Health Gap

Miami – September 29, 2026 -- eMed, a digital healthcare company, and The Female Quotient, a global media and experiences firm reaching over 8 million leaders across 30 industries, have announced a strategic partnership targeting a $1 trillion annual opportunity in the global economy by 2040 tied to closing the women's health gap.

Partnership launches at New York summit on October 14

The collaboration will officially debut at the FQ Health Summit in New York City, where executives will discuss innovation to address disparities in women's healthcare access. Chloe Ferro and Olivia Ferro, founders of sheMed, will join the discussion to share perspectives on personalized care.

PBS Biotech Embeds Rockwell Automation Tech in Cell Therapy Bioreactor

Image
PBS Biotech Embeds Rockwell Automation Tech in Cell Therapy Bioreactor

Milwaukee – September 29, 2026 -- PBS Biotech has embedded Rockwell Automation technology into its MiniPRO multi-parallel bioreactor platform, a system with up to 24 independently controlled bioreactors designed to speed cell therapy process development and reduce risk during scale-up to commercial manufacturing.

Platform integrates FactoryTalk software with PlantPAx distributed control

The MiniPRO uses Rockwell's FactoryTalk software and Process Library to deliver real-time process control within an automation environment that can integrate directly into a larger PlantPAx distributed control system used to run an entire cell-therapy facility. Rockwell Automation, headquartered in Milwaukee and employing roughly 26,000 people across more than 100 countries as of fiscal year 2025, positions the collaboration as a way to standardize automation across development and GMP manufacturing stages.

Thyme Companies Names Flatiron Health Ex-CEO Starrett to Lead New Ventures

Image
Thyme Companies Names Flatiron Health Ex-CEO Starrett to Lead New Ventures

Nashville, Tenn. – – September 29, 2026 -- Thyme Companies has appointed Carolyn Starrett as executive vice president of new ventures, tasking her with identifying and scaling new businesses beyond its existing Thyme Care platform. Starrett reports directly to Executive Chairman Robin Shah, marking her second collaboration with him after their tenure together at Flatiron Health.

Starrett brings a decade of oncology data leadership from Flatiron Health

Starrett joined Flatiron Health in 2016 alongside Thyme's founders and served as its Chief Executive Officer from 2021 to 2025. Under her leadership, Flatiron's real-world evidence platform expanded from roughly 400,000 to more than 5.5 million patient records. Its OncoEMR platform grew to serve more than 4,500 oncology providers nationwide, while the company extended research operations into the United Kingdom, Germany and Japan.